title: Usefulness of defibrotide in the treatment of vascular disorders: a clinical-pharmacologic study.
authors.affiliation: Istituto di Clinica Medica-University of Siena, Policlinico LeScotte, Italy.
authors.forename: T
authors.initials: T
authors.lastname: Di Perri
authors.forename: F
authors.initials: F
authors.lastname: Laghi-Pasini
authors.forename: C
authors.initials: C
authors.lastname: Frigerio
authors.forename: P L
authors.initials: PL
authors.lastname: Capecchi
authors.forename: G
authors.initials: G
authors.lastname: Messa
authors.forename: M
authors.initials: M
authors.lastname: Franchi
authors.forename: F
authors.initials: F
authors.lastname: Landini
authors.forename: A
authors.initials: A
authors.lastname: Burresi
authors.forename: L
authors.initials: L
authors.lastname: Caccatelli
authors.forename: A
authors.initials: A
authors.lastname: Ghezzi
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000328:Adult; D001769:Blood / Q000187:drug effects*; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D001798:Blood Proteins / Q000032:analysis; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005353:Fibronectins / Q000097:blood; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000097:blood; D011089:Polydeoxyribonucleotides / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D001798:Blood Proteins; D005230:Fatty Acids, Nonesterified; D005353:Fibronectins; D011089:Polydeoxyribonucleotides; C036901:defibrotide; D015121:6-Ketoprostaglandin F1 alpha; D007703:Peptidyl-Dipeptidase A